Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexmedetomidine plus esketamine for improving sleep quality after cesarean section
ChiCTR2600127062Phase 4Not yet recruiting
- Sponsor
- Anhui Province Maternity and Child Health Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and esketamine in Postoperative sleep disturbance (PSD), postoperative pain and postpartum depression (PPD) (3 arms), sponsored by Anhui Province Maternity and Child Health Hospital. Primary endpoints: Sleep quality on postoperative days 1-3 and Sleep efficiency on postoperative days 1-3. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
Postoperative sleep disturbance (PSD)postoperative painpostpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2600127062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127062.